Relief Therapeutics Holding SA (0QKQ.L)
LSE - LSE Delayed price. Currency in CHF
Add to watchlist
At close: 08:52AM BST
| Previous close | 1.1450 |
| Open | 1.1850 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 1.1400 - 1.1800 |
| 52-week range | 1.1400 - 8.2400 |
| Volume | |
| Avg. volume | 219 |
| Market cap | 748.057M |
| Beta (5Y monthly) | -14.70 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings date | 15 Sept 2024 - 19 Sept 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireEton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
PKU GOLIKE® is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and specialty call pointTransaction is expected to be accretive to 2024 earningsEstimated peak sales of more than $10 million annuallyU.S. phenylketonuria ("PKU") medical formula market estimated to be $100 million annually DEER PARK, Ill., March 22, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company foc
© 2024 Yahoo. All rights reserved.